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The term “anti-epileptic drug” refers to the 
currently available medical treatment against 
epilepsy. A discussion amongst the authors was 
sought to critically examine the term and identify 
possible issues. Translations in other languages 
were retrieved from literature and the usage 
confirmed by correspondence with native users 
of the language working in the medical field. 
The aim of this article is to initiate a debate by 
highlighting some negative undertones attached 
to this terminology.
  “Epileptic” is essentially understood as a 
person with epilepsy. The word has heavily 
stigmatizing undertones in many countries where 
misconceptions about the disease are rampant. 
An “Anti – epileptic drug” can then be easily 
construed to imply that that the drug is against 
an “epileptic” that is a person with epilepsy. 
 It is also scientifically incorrect since the 
currently available medications are anti-seizure 
and not curative (anti epilepsy). Thus, “anti-
seizure” is scientifically more accurate.1 
 Another issue is that whether the therapeutic 
substances used for epilepsy should be referred 
to as “drugs”. There is no distinction between the 
terms ‘drug’ and ‘medicine’ in the English medical 
literature. In the community however, ‘drugs’ 
have extended aspects pertaining to law, illegality, 
and prohibitions, whereas ‘medicines’ do not. 
‘Drugs’ do not necessarily have a therapeutic/
curative function (i.e. people use them to feel in 
a particular way) as opposed to ‘medicines’ which 
are by definition therapeutic.
 While in English the word ‘drug’ encompasses 
medicines and non-therapeutic recreational 
substances, most other languages have separate 
words for ‘drug’ and ‘medicine’. Importantly, 
the translation for ‘drug’ is perceived to mean 
only non-therapeutic recreational substances and 
has negative connotations. The above holds true 
for various languages; namely French (drogue, 
medicament), German (droge, medikamente), 
Russian (narkotikov, medikamenty), Swedish 
(droger, medikamenter), Spanish (droga, 
medicina), Turkish (uyuşturucu, ilaç), Japanese 
(doraggu, kusuri), Hindi (regional slangs for 
‘drug’, dawai for medicine), Khmer (thnam, tham 
p t), Persian (dava, daru), Arabic (eghar/mokhader, 
moxadder) and many dialects. 
 One may argue that the treatments against other 
diseases such as hypertension and diabetes are 
also referred as anti-hypertensive and anti-diabetic 
respectively. However, these diseases do not have 
stigmatic and psychological connotations; this 
is where epilepsy stands out. Epilepsy can be 
extremely stigmatizing and anything that might 
promote stigma should be driven out. Even if the 
association of the term “anti epileptic drug” with 
stigma is not strong enough; other issues raised 
in this article bring out a need for improvement 
in the current terminology.
 In conclusion, we urge that steps should be 
taken to initiate a debate on the ongoing use of 
the term “anti-epileptic drug” and revise it as 
necessary.  
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